June
30
|
March
31
|
|||||||
2007
|
2007
|
|||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ |
23,349
|
$ |
25,776
|
||||
Accounts
receivable, net of allowances for sales returns and doubtful accounts
of
$318 and $413 at June 30, 2007 and March 31, 2007,
respectively
|
6,883
|
6,634
|
||||||
Inventories,
net
|
8,640
|
5,567
|
||||||
Prepaid
expenses and other current assets
|
1,350
|
991
|
||||||
Total
current assets
|
40,222
|
38,968
|
||||||
Property
and equipment, net
|
1,312
|
1,351
|
||||||
Intangible
assets, net
|
1,087
|
1,161
|
||||||
Other
assets
|
108
|
176
|
||||||
Total
assets
|
$ |
42,729
|
$ |
41,656
|
||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
||||||||
Current
liabilities:
|
||||||||
Notes
payable and bank lines of credit
|
$ |
—
|
$ |
10
|
||||
Accounts
payable
|
3,705
|
1,974
|
||||||
Accrued
product warranty
|
1,191
|
1,101
|
||||||
Deferred
revenue
|
968
|
1,064
|
||||||
Litigation
suspense
|
19,500
|
19,500
|
||||||
Accrued
expenses and other current liabilities
|
3,244
|
3,590
|
||||||
Total
current liabilities
|
28,608
|
27,239
|
||||||
Total
long term liabilities
|
—
|
—
|
||||||
Total
liabilities
|
28,608
|
27,239
|
||||||
Commitments
and contingencies (Note 7)
|
||||||||
Stockholders’
equity:
|
||||||||
Preferred
stock; $0.01 par value; 5,000,000 shares authorized; none issued
and
outstanding
|
—
|
—
|
||||||
Common
stock; $0.01 par value; 200,000,000 shares authorized; 7,113,372
and
7,106,867 shares
issued and outstanding at June 30, 2007 and March 31, 2007,
respectively
|
71
|
71
|
||||||
Additional
paid-in capital
|
122,871
|
122,473
|
||||||
Accumulated
other comprehensive income (loss)
|
184
|
240
|
||||||
Accumulated
deficit
|
(109,005 | ) | (108,367 | ) | ||||
Total
stockholders’ equity
|
14,121
|
14,417
|
||||||
Total
liabilities and stockholders’ equity
|
$ |
42,729
|
$ |
41,656
|
||||
Three
Months Ended
June
30,
|
Three
Months Ended
June
30,
|
|||||||
2007
|
2006
|
|||||||
Revenue
|
$ |
4,598
|
$ |
6,576
|
||||
Cost
of sales
|
2,977
|
4,078
|
||||||
Gross
profit
|
1,621
|
2,498
|
||||||
Operating
expenses:
|
||||||||
Research
and development expenses
|
778
|
996
|
||||||
Sales
and marketing expenses
|
1,006
|
1,044
|
||||||
General
and administrative expenses
|
1,203
|
2,302
|
||||||
Total
operating expenses
|
2,987
|
4,342
|
||||||
Operating
loss
|
(1,366 | ) | (1,844 | ) | ||||
Other
income (expense), net
|
728
|
42
|
||||||
Net
loss
|
$ | (638 | ) | $ | (1,802 | ) | ||
Net
loss per share, basic and diluted
|
$ | (0.09 | ) | $ | (0.26 | ) | ||
Shares
used in per share computation:
|
||||||||
Basic
and diluted
|
7,110
|
7,023
|